BD to become exclusive global license partner (excluding China) for Bactiguard coated Foley catheters
STOCKHOLM, Dec. 14, 2023 /PRNewswire/ -- Bactiguard Holding AB (publ.) today announces strengthened ties with leading global medical technology company Becton Dickinson & Company (BD), Bactiguard's longest and strongest license collaboration. An interim agreement has been signed granting BD an exc...
Bactiguard enters development partnership in the dental field
STOCKHOLM, April 8, 2022 /PRNewswire/ -- Bactiguard today entered an agreement to initiate a global development partnership with Dentsply Sirona in the dental field, a new application area for the Bactiguard technology. The initial development phase, which is expected to last approximately one y...
Correction: Year-end report 2021 Bactiguard Holding AB
STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- In previous press releases regarding the year-end report for 2021, incorrect information related to "Cash flow from operating activities" has been reported. Correction is made with this press release and the correct PDF is attached for Bactiguard Holding AB...
Bactiguard presents focused growth strategy and sets new long-term financial targets
STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- Bactiguard presents new long-term financial targets in connection with the year-end report for 2021. The new financial targets relate to growth and profitability, with annual revenues of at least1 billion SEK and annual EBITDA of at least 400 million SEK in...
Bactiguard and Zimmer Biomet expand global license partnership
STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- Bactiguard and Zimmer Biomet have today agreed to expand the global license partnership, that was initiated in 2019, to cover multiple product segments. The extended exclusive license agreement covers implants for joint reconstruction (hips and knees), spo...
Clinical study on Bactiguard's endotracheal tube now published - shows significant reduction of ventilator-associated pneumonia
STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well renowned journal Annals of Intensive Care. The study shows a 53% reduction of ventilator-associated pneumonia with Bactiguard's endotracheal tube. It was presented for th...
Interim report for Q3 2021 : Bactiguard Holding AB (publ)
STOCKHOLM, Oct. 28, 2021 /PRNewswire/ -- Capital injection initiates a new phase of accelerated expansion Third quarter (July-September 2021) * Revenues amounted to SEK 45.2 (34.1) million, an increase of 32%. Adjusted for currency effects revenues increased by 36%. * EBITDA amounted to SEK ...
New clinical trial shows 53% reduction of ventilator-associated pneumonia with Bactiguard's endotracheal tube
STOCKHOLM, Oct. 5, 2021 /PRNewswire/ -- This week at the European Society of Intensive Care congress (ESICM), a study from Liège,Belgium on Bactiguard's endotracheal tubes was presented. The study showed a 53% reduction in ventilator-associated pneumonia (VAP) in intensive care patients, intubate...
Bactiguard appoints new CEO
The Board of Bactiguard Holding AB (publ) has today appointed Anders Göransson as the new CEO. Anders has extensive experience from consulting within McKinsey and has held several senior positions in Amgen, most recently as Head of Innovation Europe. Anders will start his employment in Bactiguard...
A large randomized clinical trial shows significant reduction in urinary tract infections
STOCKHOLM, March 12, 2021 /PRNewswire/ -- A recently published, randomized, controlled multicenter study inIndia shows that urinary catheters with Bactiguard's coating for infection prevention reduce the risk of catheter-associated urinary tract infections (CAUTI) by 69% compared to standard cat...
Health Canada provides COVID-19 Interim Order approval for Bactiguard's TempSensor catheter
STOCKHOLM , Feb. 9, 2021 /PRNewswire/ -- Health Canada has approved Bactiguard's urinary catheter with temperature sensor for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguard's catheters can reduce the risk of secondary infections for critically ill...
Bactiguard-coated Zimmer Biomet trauma implants receive European regulatory clearance
STOCKHOLM, Jan. 22, 2021 /PRNewswire/ -- Today, Bactiguard-coated Zimmer Biomet orthopaedic trauma implants received European regulatory clearance and CE mark. Preparations for registering the implants in the U.S. market are also ongoing. "I am very pleased that the CE mark has been secured for B...
Bactiguard: New order from China
STOCKHOLM, Dec. 30, 2020 /PRNewswire/ -- Bactiguard has received an initial order for coating concentrate from Well Lead Medical (Well Lead) inChina. The order will be delivered promptly and generate license revenues in the fourth quarter 2020 of approximately SEK 9 million. In parallel with th...
Bactiguard maintains clear growth strategy and updates financial targets
STOCKHOLM, Nov. 5, 2020 /PRNewswire/ -- Bactiguard presents updated financial targets for 2025 in connection with the company's financial report for the third quarter of 2020. Bactiguard's growth strategy for the coming five-year period up to 2025 is based on a continued roll-out of Bactiguard's...
Health Canada provides COVID-19 Interim Order approval for Bactiguard's endotracheal tubes
STOCKHOLM, Aug. 13, 2020 /PRNewswire/ -- Health Canada has approved Bactiguard's endotracheal tubes for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguard's endotracheal tubes can reduce the risk of secondary infections for critically ill patients. "...
Hydrocyn® aqua Inactivates the Coronavirus Causing COVID-19
STOCKHOLM, June 3, 2020 /PRNewswire/ -- The effect of Hydrocyn® aqua (Hydrocyn) on the new coronavirus (SARS-CoV-2) causing COVID-19 has been confirmed. Tests performed by the Swedish National Veterinary Institute show that 99.9% of the virus particles were killed after exposure to Hydrocyn. Bact...
Bactiguard Launches Product That Protects Against Coronavirus
STOCKHOLM, March 12, 2020 /PRNewswire/ -- Bactiguard launches HYDROCYN aqua®, a water-based product that has been proven to have a powerful effect on killing previous variants of coronavirus within 15-30 seconds. Previous experience shows that the proven effect can be transferred to new variants ...
Bactiguard Donates Infection Prevention to China
STOCKHOLM, March 4, 2020 /PRNewswire/ -- In the fight against the Corona virus, Bactiguard donates products for infection prevention to Chinese hospitals, at a market value of over2 million SEK. "To help fight the new corona virus (covid-19) and protect the most severely ill patients, we will do...
Bactiguard Completes Acquisition of Vigilenz
STOCKHOLM, March 2, 2020 /PRNewswire/ -- Bactiguard Holding AB (publ) ("Bactiguard") has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), which was announced on4 February 2020. All conditions precedent have been fulfilled and the first part...
Year-end Report 2019 Bactiguard Holding AB
STOCKHOLM, Feb. 5, 2020 /PRNewswire/ -- A strong development in fourth quarter earnings, combined with the licensing deal with Zimmer Biomet led to the highest full-year result in Bactiguard's history. The financial effects of both increased BIP sales and new license revenues clearly show that ou...
